SurgiMab Competitors and Similar CompaniesClear all
SurgiMab's competitors and similar companies include Microvascular Therapeutics and Curasight.
 Microvascular Therapeutics Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100. |  Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | ||
Founding Date | Founding Date 2011 | Founding Date 2016 | Founding Date 2013 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Montpellier, FR HQ Grabels, FR | Locations Tucson, US HQ | Locations København, DK HQ |
Employees | Employees 614% decrease | Employees 1220% increase | Employees 7 |
For sources of this data, please see the company profile
View Company Profiles
Microvascular Therapeutics
HQ
Tucson, US
Employees
12↑ 20% increase
Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100.
View companyCurasight
HQ
København, DK
Employees
7
Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR).
View company